SEC Form 4 · accession 0001209191-16-123090
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith R Leonard
Director
Period of report
May 23, 2016
Accepted (ET)
May 24, 2016 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 23, 2016 | M | 9,000 | $14.22 | A | 9,794 | D | |
| Common Stock | May 23, 2016 | S | 9,000 | $99.70 | D | 794 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $14.22 | May 23, 2016 | M | 9,000 | D | — | May 29, 2024 | Common Stock | 9,000 | 18,000 | D |
Explanation of responses
- F11/3rd of the shares subject to the option shall vest and become exercisable in a series of three equal annual installments measured from May 29, 2014.